Alan Hilary Calvert

Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies.

Christopher Calabrese, Michael A. Batey, Huw D. Thomas et al. · PubMed · 2003 · 79 citations

Medicine, Oncology, Pharmacology +14

Biochemical pharmacology of pemetrexed.

Alan Hilary Calvert · PubMed · 2004 · 29 citations

Medicine, Oncology, Pharmacology +14

Phase 1/2 study of oral rucaparib: Final phase 1 results.

Rebecca Kristeleit, Howard A. Burris, Patricia LoRusso et al. · Journal of Clinical Oncology · 2014 · 27 citations

Pharmacy, Oncology, Pharmacology +14

A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors.

Rebecca Kristeleit, Geoffrey I. Shapiro, Patricia LoRusso et al. · Journal of Clinical Oncology · 2013 · 23 citations

Pharmacy, Oncology, Pharmacology +10

Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas

Ramón Salazar, Ruth Plummer, Ana Oaknin et al. · Investigational New Drugs · 2010 · 13 citations

Medicine, Oncology, Pharmacology +16